Unknown

Dataset Information

0

Nomograms predicting Overall Survival and Cancer-specific Survival for Synchronous Colorectal Liver-limited Metastasis.


ABSTRACT: Background: Colorectal cancer (CRC) ranks as the third most frequent cancer type and the second leading cause of cancer-related death worldwide. The liver is the most common metastatic site of CRC with 20%-34% of patients suffering synchronous liver metastasis. Patients with colorectal liver-limited metastasis account for one-third of deaths from colorectal cancer. Moreover, some evidence indicated that CRC patients with synchronous liver disease encounter a worse prognosis and more disseminated disease state comparing with metastatic liver disease that develops metachronously. Methods: Data in this retrospective analysis were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Nomograms were constructed with basis from a multivariate Cox regression analysis. The prognostic nomograms were validated by C-index, time-dependent receiver operating characteristic (ROC) curve, decision curve analysis (DCA) and calibration curves. Results: A total of 9,958 CRC patients with synchronous liver-limited metastasis were extracted from the SEER database during 2010-2016. Both overall survival (OS) and cancer-specific survival (CSS) were significantly correlated with age, marital status, race, tumor location, pathological grade, histologic type, T stage, N stage, surgery for primary tumor, surgery for liver metastasis, chemotherapy and CEA. All of the significant variables were used to create the nomograms predicting OS and CSS. C-index values, time-dependent ROC curves, DCA curves and calibration curves, proved the superiority of the nomograms. Conclusions: Our research investigated a national cohort of almost 10,000 patients to create and verify nomograms based on pathological, therapeutic and demographic features to predict OS and CSS for synchronous colorectal liver-limited metastasis (SCLLM). The nomograms may act as an excellent tool to integrate clinical characteristics to guide the therapeutic choice for SCLLM patients.

SUBMITTER: Li Y 

PROVIDER: S-EPMC7532510 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nomograms predicting Overall Survival and Cancer-specific Survival for Synchronous Colorectal Liver-limited Metastasis.

Li Yuqiang Y   Liu Wenxue W   Zhao Lilan L   Güngör Cenap C   Xu Yang Y   Song Xiangping X   Wang Dan D   Zhou Zhongyi Z   Zhou Yuan Y   Li Chenglong C   Pei Qian Q   Tan Fengbo F   Pei Haiping H  

Journal of Cancer 20200827 21


<b>Background:</b> Colorectal cancer (CRC) ranks as the third most frequent cancer type and the second leading cause of cancer-related death worldwide. The liver is the most common metastatic site of CRC with 20%-34% of patients suffering synchronous liver metastasis. Patients with colorectal liver-limited metastasis account for one-third of deaths from colorectal cancer. Moreover, some evidence indicated that CRC patients with synchronous liver disease encounter a worse prognosis and more disse  ...[more]

Similar Datasets

| S-EPMC8257089 | biostudies-literature
| S-EPMC7163106 | biostudies-literature
| S-EPMC7785774 | biostudies-literature
| S-EPMC7218119 | biostudies-literature
| S-EPMC8704180 | biostudies-literature
| S-EPMC6250111 | biostudies-other
| S-EPMC8678051 | biostudies-literature
| S-EPMC7057917 | biostudies-literature
| S-EPMC7164422 | biostudies-literature
| S-EPMC7212166 | biostudies-literature